Pharmacovigilance and Risk Management

The guideline on GVP was a key deliverable of the 2010 pharmacovigilance legislation.

Each chapter and revisions are developed by a team consisting of experts from EMA and from EU Member States.

The guideline on GVP is divided into chapters that fall into two categories:

modules covering major pharmacovigilance processes;

.product- or population-specific considerations.

.Modules covering major pharmacovigilance processes

 

  • risk management
  • Drug
  • bioequivalence
  • generic drugs

Related Conference of Pharmacovigilance and Risk Management

July 27-28, 2026

19th World Drug Delivery Summit

Paris, France
July 27-28, 2026

39th World Congress on Pharmacology

Rome, Italy
September 24-25, 2026

6th World Congress on Rare Diseases & Orphan Drugs

Paris, France
November 26-27, 2026

5th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 26-27, 2026

5th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland

Pharmacovigilance and Risk Management Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in